IIM
CRMD icon

INTECH Investment Management’s CorMedix CRMD Stock Holding History

INTECH Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
18,847
+1,077
+6% +$8.51K ﹤0.01% 1866
2026
Q1 		$121K Sell
17,770
-16,900
-49% -$125K ﹤0.01% 1861
2025
Q4 		$403K Buy
34,670
+1,122
+3% +$12.4K ﹤0.01% 1612
2025
Q3 		$390K Sell
33,548
-8,947
-21% -$108K ﹤0.01% 1699
2025
Q2 		$524K Sell
42,495
-454
-1% -$5.01K ﹤0.01% 1589
2025
Q1 		$265K Buy
42,949
+18,886
+78% +$195K ﹤0.01% 1958
2024
Q4 		$195K Buy
24,063
+9,368
+64% +$93.6K ﹤0.01% 2041
2024
Q3 		$119K Buy
+14,695
New +$79.5K ﹤0.01% 1856

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

INTECH Investment Management's CRMD Position: Q2 2026 in Review

INTECH Investment Management increased its CorMedix (CRMD) stake by 6.1% in Q2 2026, buying an estimated $8.51K and bringing the position to 18,847 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1866.

INTECH Investment Management first reported a position in CRMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $524K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • INTECH Investment Management held 18,847 shares of CorMedix worth $148K as of Q2 2026.
  • INTECH Investment Management bought 1,077 CorMedix shares in Q2 2026, an estimated $8.51K.
  • CorMedix made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1866 holding.
  • INTECH Investment Management first reported a position in CorMedix in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's CorMedix position peaked at $524K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.